Resmed Acquires Somnoware, A Leader In Digital Sleep And Respiratory Care Diagnostics Software
Acquiring Company
ResMed
Acquired Company
Somnoware
San DiegoCosta MesaMobileHealth CareSportsMedical DeviceSoftwareMobileHealth CareDescription
ResMed (NYSE: RMD, ASX: RMD) today announced the acquisition of privately held Somnoware, a U.S. leader in sleep and respiratory care diagnostics software.
Quick answer
ResMed is acquiring Somnoware, announced July 5, 2023. ResMed is based in San Diego, California, United States.
- How much did ResMed pay for Somnoware?
- The deal value was not disclosed.
- What does ResMed do?
- At ResMed (NYSE: RMD, ASX: RMD) we pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives.
- Where are ResMed and Somnoware based?
- ResMed is based in San Diego, California, United States. Somnoware is based in Costa Mesa, California, United States.
- Who are the decision-makers at ResMed?
- Fundz holds 3 contacts at ResMed. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who to call at ResMed, and when
When ResMed changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day ResMed raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at ResMed, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at ResMed. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment ResMed makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Somnoware?
Somnoware was acquired by ResMed, based in San Diego. The deal was reported on July 5, 2023. At ResMed (NYSE: RMD, ASX: RMD) we pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. ResMed is publicly traded (RMD) and operates in Mobile.
When did ResMed acquire Somnoware?
ResMed's acquisition of Somnoware was reported on July 5, 2023. ResMed (NYSE: RMD, ASX: RMD) today announced the acquisition of privately held Somnoware, a U.S. leader in sleep and respiratory care diagnostics software. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Somnoware do?
The platform orchestrates data flow between 100+ medical devices, unifies datasets within a single platform, delivers high-impact analytics, enables faster diagnosis, proactive intervention, & automated patient engagement. It is privately held, operating in Software, and is based in Costa Mesa.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.